Myocardial performance in elderly patients after cardiopulmonary bypass is suppressed by tumor necrosis factor

The Journal of Thoracic and Cardiovascular Surgery

Volumn 110, Issue 6, 1995, Pages 1663-1669

  te Velthuis, Henk ^a   Jansen, Piet G M ^a   Oudemans van Straaten, Heleen M ^a   Sturk, Augueste ^a   Eijsman, León ^a   Wildevuur, Charles R H ^a  

^a Amsterdam and Leiden ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BODY SURFACE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; ENDOTOXEMIA; FEMALE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE PERFORMANCE; HEART STROKE VOLUME; HUMAN; INTENSIVE CARE; LUNG ARTERY PRESSURE; LUNG CAPILLARY PRESSURE; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

AGE FACTORS; AGED; CARDIOPULMONARY BYPASS; CASE-CONTROL STUDIES; COMPARATIVE STUDY; CORONARY ARTERY BYPASS; ENDOTOXINS; FEMALE; HEMODYNAMICS; HUMAN; MALE; MIDDLE AGE; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; PULMONARY WEDGE PRESSURE; TUMOR NECROSIS FACTOR; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 0028858365     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5223(95)70028-5     Document Type: Article

References (14)

1. Activation of coagulation after administration of tumor necrosis factor to normal subjects
2. Recombinant human tumor necrosis factor produces hemodynamic changes characteristic of sepsis and endotoxemia
3. Negative inotropic effects of cytokines on the heart mediated by nitric oxide
4. Endotoxin release and tumor necrosis factor formation during cardiopulmonary bypass
5. Heparin-coated circuits reduce the inflammatory response to cardiopulmonary bypass
6. Complement and the damaging effects of cardiopulmonary bypass
7. Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways
8. Endotoxemia associated with cardiopulmonary bypass
9. Formation of C5a during cardiopulmonary bypass: inhibition by precoating with heparin
10. Perfusion-related factors of endotoxin release during cardiopulmonary bypass
11. A method of uniform stratification of risk for evaluating the results of surgery in acquired adult heart disease
12. Morbidity and mortality of coronary bypass grafting in patients 70 years of age and older
13. Endotoxin testing in blood
14. Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-α in conscious dogs